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Aim: To explore possible inter-relationships of various biomarkers of inflammation and lifestyle and other
cardiovascular risk factors (age, gender, smoking history, hypertension, Type 2 diabetes, dyslipidemia, al-
teration of circadian rhythms, body mass index, calf circumference, thigh circumference, abdominal cir-
cumference) in the Mugello study oldest old. Methods: In 399 noninstitutionalized nonagenarians (291
women), whole blood cells, mean platelet volume, C-reactive protein, uric acid, gamma-glutamyl trans-
ferase were assessed. Results: Aging resulted as the only independent determinant for uric acid (<0.05),
and abdominal circumference for C-reactive protein. Female gender (<0.01), and thigh circumference
(<0.05) remained as determinants for mean platelet volume, age (<0.01), and male gender (<0.01) for
gamma-glutamyl transferase, and Type 2 diabetes (≤0.01) and alteration of circadian rhythms (<0.05) for
whole blood cells. Conclusion: Several inflammatory parameters remain associated with adverse lifestyle
and cardiovascular risk factors even among nonagenarians.
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Various lifestyle factors, including overweight, blood pressure and exercise, characterized by a certain grade of
inflammation and oxidative stress, are related to mortality and longevity [1]. Conversely, different oxidative and
inflammatory parameters have been associated to aging processes and chronic diseases. Specifically, a chronic,
low-grade oxidative stress and inflammatory status likely characterized the onset and development of different
age-related conditions, including cardiovascular (CV) disease [2]. In particular, uric acid (UA), a potent antioxidant,
majorly responsible for antioxidant blood power, has been correlated with CV risk and events at higher levels [3].
C-reactive protein (CRP), an acute phase protein, has been found to be associated with disability, CV disease and
mortality [4]. Various parameters obtained by hemochrome analysis, among which the white blood cells (WBC),
and mean platelet volume (MPV), could be used as simple systemic inflammatory biomarkers [5–8]. Specifically,
WBC has been identified as a predictor of CV risk and mortality [5,6]. Interestingly, MPV, a marker of platelet
function, can be considered a potential link between inflammation and thrombosis and it has recently emerged
as an effective marker of cardiometabolic risk [7,8]. Moreover, also GGT is associated with the development of
CV disease and related risk factors, including diabetes, hypertension, dyslipidemia and retains pro-oxidant and
pro-inflammatory properties [9,10].
Nonetheless, the significance of these oxidative stress and inflammatory biomarkers in very old cohorts is
generally scarce, also considering that the information and reference values available for biomarkers commonly
used in clinical routine may change with aging. Thus, studies focused on the relationship between oxidative stress
and inflammatory biomarkers and lifestyle factors appear relevant to identify new potential interventional targets
and improve our limited knowledge of the underlying pathophysiology in the oldest old population.
The Mugello study was conducted in the Mugello area, north eastward of Florence, Tuscany, Italy, which holds
a high percentage of oldest old subjects in comparison to other Italian territories [11–13]. In this extraordinary
population cohort, which included a large amount of subjects over 90 years, we assessed the distribution of the
above reported and most commonly used biomarkers (CRP, UA, MPV, GGT, WBC), evaluating if their levels are
modulated by gender, age, anthropometric measures, CV risk factors and lifestyle habits.
Materials & methods
Participants
Results presented are based on data from the Mugello study, an epidemiologic, retrospective, single-center study
on a large number of oldest old living in the Mugello area, whose details have been previously described [11]. In
this survey, subjects have been evaluated for various health issues, including presence and extent of diseases, aspects
related to nutritional status and routine hematology and biochemistry, and data collected in the Mugello Study
database. Participation rate was high among oldest old epidemiologic studies, corresponding to 69%.
Smoking was considered as a dichotomic variable, ‘never smoked’ versus ‘current or former smoker’. Circadian
rhythm alteration (sCR) was defined according to presence of insomnia, irregular sleep-wake pattern, advanced
sleep phase syndrome. Comorbid conditions, such as diabetes, hypertension, dyslipidemia – among others, were
also considered as dichotomy variables and ascertained according to pre-established algorithms that combined
information gathered from medical history, medical records, clinical examination and the blood and instrumental
tests included in the Mugello study protocol [11].
The Mugello study protocol complied with the principles of the Declaration of Helsinki on clinical research
involving human beings, and it was approved by the Institutional Review Board. Participants, or their proxies,
signed the informed consent form to be included in the study and to undergo blood withdrawal. Among the
Mugello Study participants, 399 subjects (291 women, mean ± SD age 93.1 ± 3.2 years), had complete data to
be included in this analysis.
Anthropometric measurements
Weight, ulna length, mid-upper arm circumference (MUAC), and calf circumference (CC) were measured as we
previously described according to the standard procedures [12]. Weight was measured using a portable scale, and
ulna length, MUAC and CC were measured using a nonstretchable fiberglass insertion tape. MUAC was measured
halfway between the acromion and the olecranon process. The ulna length was measured between the olecranon
and the midpoint of the styloid process; ulna length was used to estimate the subject height according to the MUST
(BAPEN). Body mass index (BMI) was calculated from weight (W), in kilograms, and height (H), in meters,
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according to the formula: W/(H)2. CC was measured by wrapping the tape around the widest part of the calf.
MUAC and CC values were classified according to the following cut-offs: 21 and 22 cm for MUAC, and 31 cm
for CC [12].
Biochemical variables
UA serum levels were analyzed using enzymatic-colorimetric methods (Roche Diagnostics GmbH, Mannheim,
Germany) [13]. The lower LODs were 0.2 mg/dl, range 0.2–25.0. Intra- and interassay variation coefficients were
0.5 and 1.7%, respectively.
High-sensitivity CRP was measured in duplicate using an ELISA and colorimetric competitive immunoassay
that used purified protein and polyclonal anti-CRP antibodies. Values of white blood count and mean platelet
volume (plasma-EDTA; XT 1800 SYSMEX DASIT, Japan), GGT (serum), and UA (serum) and CRP (serum)
(DXC 600 Beckman Coulter, CA, USA) were measured.
Statistical analysis
Data are reported as mean ± standard deviation or as a percentage. Statistical analysis performed included Student’s
t-test, χ2 test for continuous and categorical variables, respectively.
Continuous variables showing a markedly skewed distribution (CRP, GGT) were log-transformed before being
entered into calculations. Log-transformed values were then back-transformed for data presentation. Categorical
or continuous variables and independently associated with the dependent variable with a p-value < 0.05 at the
univariate analysis, entered in a multivariate regression model.
Analyses were performed using the statistical package Statview, version 5.0.1 (SAS Institute, Abacus Concept,
Inc., CA, USA).
A p-value ≤ 0.05 was considered statistically significant.
Results
Characteristic of subjects
The anthropometric and clinical characteristics of the 399 nonagenarian subjects in the overall population and
according to gender are reported in Table 1. Males had higher AC and CC, and a higher risk for smoking history
(p < 0.001) than women (Table 1). Instead, women were older than men (≤0.01), and hypertension (p < 0.01),
physical inactivity (<0.001) and the metabolic syndrome (MetS; ≤0.001) appeared to be more frequent in women
than in men (Table 1). Among biochemical parameters, MPV was significantly higher and GGT was lower in
females with respect to males (Table 1). No significant differences were observed according to the gender for the
other anthropometric parameters and lifestyle factors considered (Table 1).
Oxidative/inflammatory biomarker distribution & correlation
Considering that the information and reference values available for biomarkers commonly used in clinical routine
changes with aging, we had evaluated the distribution of GGT, UA, CRP, MPV and WBC in the nonagenarian
subjects enrolled in this study to verify their distribution against reference values used for clinical routine in our
laboratory (Figure 1, panel A–E, respectively).
In this context, we found that 14, 28, 21, 9, and 5% of Mugello oldest old subjects presented values higher than
the high reference values utilized in our laboratory and corresponding respectively to <38 IU/l for females and
<55 IU/l for males for GGT, <6 mg/dl for females and <7.2 mg/dl for males for UA, <1 mg/dl for CRP, <12 fl
for MPV and 10*109/l for WBC (Figure 1).
In Table 2, the coefficients of correlation and the p-values obtained by the simple regression analysis among the
biomarkers studied were reported. In particular, CRP levels correlated with all the other biomarkers (UA, MPV,
GGT, WBC). Moreover, a significant direct association was also observed between UA and GGT.
Biomarkers lifestyle determinants in oldest old
In Table 3, we reported the multivariate analysis between all the parameters listed in Table 1 and the biomarkers
analyzed. The only parameter associated with UA was aging (0.11, 2, ≤0.05) (Table 3).
Exploratory analyses revealed several significant independent associations between AC with CRP, gender and LC
with MPV, as well as between age and male gender and GGT (Table 3).
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Table 1. Mugello study population characteristics.
Characteristics Overall population Men Women p-value
n 399 108 291
Age (years) 93.1 ± 3.2 92.4 ± 2.6 93.3 ± 3.3 ≤0.01
Hypertension 230 (57) 50 (46) 180 (62) 0.01
Diabetes 58 (14) 13 (12) 45 (15) ns
Dyslipidemia 44 (11) 11 (11) 33 (11) ns
MetS (NCEP-ATP III) 108 (27) 18 (16) 90 (31) ≤0.001
Alteration of circadian rhythms 7 (2) 3 (3) 12 (4) ns
Physical inactivity 44 (41) 170 (60) 0.001
Smoking history 120 (30) 77 (72) 43 (15) 0.001
Mean blood pressure 93 ± 10 92 ± 10 93 ± 11 ns
Body mass index (kg/m2) 25 ± 5 25 ± 3 25 ± 5 ns
Abdominal circumference 96 ± 13 100 ± 12 94 ± 13 0.001
Leg circumference 45 ± 7 44 ± 5 45 ± 8 ns
Calf circumference 32 ± 5 33 ± 4 31 ± 5 0.001
Laboratory biomarkers:
– Uric acid (mg/dl) 5.7 ± 1.8 5.8 ± 1.4 5.6 ± 1.9 ns
– C-reactive protein (mg/dl) 0.4 (0.02–24.7) 0.42 (0.02–20.2) 0.41 (0.02–24.7) ns
– Mean platelet volume 11 ± 1.0 11 ± 1.0 10 ± 1.0 0.05
– Gamma-glutamyl transferase
(IU/l)
17 (3–220) 19 (6–162) 16 (3–220) 0.01
– White blood count (*109/l) 6.4 ± 1.9 6.5 ± 1.9 6.3 ± 1.9 ns
Data are given as mean ± SD for normally distributed variables, and as median and interquartile range for no-normally distributed parameters. Categorical data are presented as numbers
(percentages).
Table 2. Correlation between uric acid, C-reactive protein, mean platelet volume, gamma-glutamyl transferase and white
blood cells.
Uric acid Mean platelet volume Gamma-glutamyl transferase White blood count
r-value p-value r-value p-value r-value p-value r-value p-value
C-reactive
protein
0.17 0.01 -0.21 0.001 0.17 0.001 0.29 0.001
Uric acid -0.02 ns 0.12 0.05 0.08 ns
Mean platelet
volume
-0.07 ns -0.05 ns
Gamma-
glutamyl
transferase
-0.03 ns
Subjects with circadian rhythm alteration or T2D showed higher WBC with respect to those without these
conditions (Table 3). Both factors remained independently related to WBC at the multivariate analysis (Table 3).
Discussion
Characteristic of subjects
Interestingly, in our oldest old population, we observed a low percentage of dyslipidemic subjects, with a very low
percentage of subjects taking statins (7 and 11% in females and males, respectively). These percentages resulted
significantly lower than those observed in younger age classes [14]. Nonetheless, these data confirmed the ones
obtained in another Italian cohort of elderly subjects, indicating that both TotCH and TG resulted lower in oldest
old with respect to elderly subjects [15]. All together these observations may suggest that lipid alteration might
represent a strong determinant for mortality. In this context, specific lipid genotype (e.g., the apolipoprotein E
[APOE] e2/3/4 polymorphism and the APOB rs1042034 [C/T]) and phenotype (e.g., HDL and LDL particle
sizes) has been found strong predictors for longevity and life span [16,17].
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Figure 1. Distribution of gamma-glutamyl transferase, uric acid, C-reactive protein, mean platelet volume and white blood cells in the
studied population.
In the Mugello cohort, also percentage of obesity did not result high, 11 and 14% in male and female subjects.
This fact may be beneficial in terms of survival. However, although longevity may be limited by the increased
prevalence of obesity, some protective factors, as adiponectin, a serum protein expressed and secreted exclusively
by adipose tissue, may retain a protective role against insulin resistance and atherosclerosis during aging [18], so this
issue merits to be evaluated in the future study.
Interestingly, in a prospective study of healthymiddle-age men, overweight and physical inactivity (in no-smoker)
and smoking habit resulted as strong determinants of longevity (defined as reaching at least 85 years of age) [19].
In the Mugello study, the females were less active with respect to males (60 vs 42% the percentage of inactive
subjects in the two genders, p < 0.001), while 30, 9 and 1% in females and 30, 26 and 2% in males performed
light physical activity (2–4 h/week), moderate physical activity (>4 h/week or moderate [3–6 METs] physical
activity 1–2 h/week) or intense ([>6METs] physical activity several times a week), respectively. We did not observe
any relationship between physical activity and the biomarkers considered. These findings are in agreement with
the previous ones, showing that inflammatory components such as IL-1β, TNF-α, IL-6, IL-18 and CRP have
inconsistent associations with different aspects of physical performance, obtained in older people (70–79 years) [20].
Moreover, we did not find any association between current or former smoking and risk factors considered, in
agreement with previous data obtained in nonagenarians, which showed no role of smoking habit in systolic
blood pressure or dyslipidemia, differently from the association of smoking habits with dyslipidemia in younger
cohorts [21,22].
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Oxidative/inflammatory biomarker distribution & correlation
‘Inflamm-aging’, a chronic and low-grade inflammation that characterizes aging, appears to have important roles
in late life [23,24]. In the Mugello oldest old, the percentage of subjects with levels higher than the high reference
values varied according to the biomarker considered, from the lowest 5% for WBC (12*109/l), to 28% for UA
(<6 mg/dl for females and <7.2 mg/dl for males). Moreover, the fact that we found that some biomarker increase
with aging supports the hypothesis of ‘inflamm-aging’.
Uric acid
We did not find any gender-related difference, whereas generally higher levels of UA are found in men than in
women. Specifically, the lower UA plasma levels found in woman in younger age ranges has been attributed to
the role of steroids in UA regulation, also called ‘uricosuric effect’, and to the possible urate depressing effect of
estrogens in women [25]. However, results similar to our data were observed in the only study that evaluated a large
Chinese population of older people (18,906 Chinese elderly aged 65 and older, which included a group of about
120 oldest old subject >85 years) [26].
Another interesting point is that althoughUA is not included between criteria for diagnosingmetabolic syndrome
(MetS), many studies have evidenced a positive association between UA and MetS in patients of various ages and
ethnicities [3,27]. However, the lack of this relationship observed in our population is in agreement with the previous
results, evidencing a higher MetS risk in the population ranging 65–74 years, but not in the oldest old subgroup
(85 and over) [26]. The reason for this finding is unclear but could be explained by ‘successful aging’, characterized
by a high level of functioning across several domains, against usual aging, in other words, functioning well but with
a high risk of comorbidity and disability. Worthy of note, among the Mugello study participants, 32% were free
from disabilities on the five-item basic ADL (bathing, dressing, toileting, transfer and feeding), 39% were able to
walk independently without any aid and 56% showed Mini Mental State Examination raw scores ≥21, which is
generally considered as a cut-off value for cognitive impairment in older persons. Further, 22% lived alone needing,
at most, some occasional support for heavy house chores.
C-reactive protein
CRP correlated with other different oxidative and inflammatory biomarkers, in agreement with previous ones
obtained in younger age ranges [9,28]. Moreover, we found that AC was the only variable independently related
to CRP. Interestingly, an association between increased CRP and obesity features has been previously found in
younger age ranges, suggesting the possible use of CRP as additive biomarker to identify high-risk obese subjects
also in the oldest old group [29].
White blood count
T2D and circadian rhythm alteration resulted independently related to WBC at the multivariate analysis. Ac-
cordingly, a meta-analysis, which included data about the association between WBC count and T2D from 20
cross-sectional and prospective cohort observational studies (8647 T2D cases and 85,040 non cases) confirmed
that raisedWBC is associated with higher risk of T2D [30]. Moreover, we also observed a direct relationship between
WBC and fast glicemia (r = 0.9, p≤ 0.05) and glycated hemoglobin (r = 0.22, p< 0.001; data not shown). A reverse
causality effect is also proposed because hyperglycemia itself may have an effect on WBC values, as antidiabetic
drugs, such as rosiglitazone or acarbose, may lower WBC levels [31,32]. However, we did not observe this effect as
subjects taking antidiabetic treatments presented higher levels of WBC with respect to those not taking these classes
of drugs (6.9 ± 2 vs 6.3 ± 1.9*109/l, p < 0.05, data not shown).
Sleep
Sleep disturbance and desynchronization between endogenous rhythm and behavioral cycles are common among
elderly people and represent important health issues for their relationship with an adverse metabolic profile, and a
proinflammatory condition which can increase the risk of CV disease and early mortality. Although the mechanisms
underlying these associations are not fully understood, data in younger age classes have evidenced the role of systemic
inflammation through increases in WBC count, confirmed in our Mugello population [33,34]. If further studies
will confirm this relationship also in the oldest old, approaches to lower disease risk associated with increased
sleep-related inflammation should be evaluated in this particular population.
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Mean platelet volume
In younger classes of age, MPV resulted increased in obese patients, with concurrent reversal of such variable
after weight loss [35]. This fact may be related to increase of circulating reticulated cells, which represent young,
mRNA-rich platelets retaining a high pro-aggregating and hemostatic power [36]. However, we did not find any
differences between MPV levels in obese and nonobese subjects (10.8 ± 1.1 vs 10.7 ± 1 fl, p = ns, data not shown).
Nonetheless, we observed an independent association between MPV and TC, which is an important nutritional
and muscular mass index, especially in the elderly, which merits further deepening.
Gamma-glutamyl transferase
The relationship between aging and GGT that we observed in the Mugello cohort has been previously described in
both genders of younger age, whereas males presented higher GGT levels than females [37,38]. Interestingly, GGT
is emerging as a new strong and independent MetS determinant in middle age subjects [39,40]. However, our data
did not support the association between GGT and MetS, thus GGT could not be an effective marker to identify
this condition in nonagenarians.
Study limitation
One limitation can be related to the fact that some other important variables (e.g., socioeconomic status, social
relationship and measurement of frailty index) might have a confounding effect on the results, but were not
accounted in this analysis. As an example, it was not possible to assess what impact might have level of independence
and quality of life, which were not, after all, in the focus of the present study. However, it is possible to recover all
these parameters from the Mugello database, and undertake further studies which address this limitation in order
to provide greater insights on this exceptionally elderly population.
Clinical implication
This study may inform about the levels of different risk and disease biomarkers still largely unknown in the oldest
old subjects, so improving prevention and cure in this group of subjects, which represent the fastest growing section
of the population by now. In this context, more knowledge about biological aspect of aging and the identification of
critical biomarkers in healthy aging may also represent a useful tool for public health planning, allowing to promote
a correct lifestyle and wellbeing across the life span, and prevent disabilities beyond the biological, psychological
and social barriers that aging entails.
Conclusion
Several inflammatory parameters remain associated with adverse lifestyle and CV risk factors even among nona-
genarians. Lifestyle modification and risk factor control could reduce inflammation and promote a healthy aging
even at extreme old age.
Summary points
• The possible inter-relationships of various biomarkers of inflammation and lifestyle and other cardiovascular risk
factors in oldest old of the Mugello study were evaluated.
• Several inflammatory parameters remain associated with adverse lifestyle and cardiovascular risk factors even
among nonagenarians.
• Lifestyle and risk factor control could face inflammation and promote a healthy aging even at extreme old age.
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